+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Red Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Pre Book Price: $ 5216

Original Price: $ 5795

Global Red Biotechnology Market: Snapshot

Red biotechnology involves the application of biotechnology in the production of biopharmaceuticals and pharmaceuticals. Biotechnology is increasingly gaining prominence in medicine over the last few years. The global biotechnology market is gaining from evolution of the healthcare industry to provide advanced diagnostics and novel line of treatment for medical conditions.

Red biotechnology aka medical biotechnology involves the development of novel therapeutic procedures and advanced diagnostics. The application of biotechnology in pharmaceutical and biopharmaceutical segments involve examination of cells and tissues, stem cells, orphan drugs, pharmacogenetics, genetic testing, gene therapy, and proteomics. Red biotechnology is primarily used for neurosciences and protein research.

The application of biotechnology in pharmaceuticals has helped the healthcare industry discover line of treatment for almost 5,000 to 8,000 rare diseases that affect almost 27 to 63 million people worldwide, which represents 6-8% of the global population. Red biotechnology has also helped for the diagnosis and treatment of an array of life-threatening diseases. Furthermore, advances in biotechnology for pharmaceutical and biopharmaceutical industry have improved treatment efficacy considerably. For instance, the application of red biotechnology in the pharmaceutical industry have improved survival rate of most cancers.

Currently, North America holds supremacy in the global red biotechnology market followed by Europe. North America typically is a pioneer in the introduction of new products and is an early adopter of integration of advanced sciences for public welfare. Europe also exhibits strong hold in the global red biotechnology market. Emerging economies in Asia Pacific, Latin America, and the Middle East and Africa are anticipated to emerge as lucrative markets for red biotechnology in the upcoming years, owing to the need for affordable treatment for several diseases and rising healthcare expenditure in these regions.

Red biotechnology is the application of biotechnology in biopharmaceuticals and pharmaceuticals production. It provides patients with innovative and modern modes of diagnostics and treatments. This biotechnological application involves research and study on cells and tissues, genetic testing, stem cells, gene therapy, orphan drugs, proteomics and pharmacogenetics. The red biotechnology mainly focuses on neurosciences and protein research.

The global market for red biotechnology is categorized by applications and product types as follows:

  • Applications

    • Drug discovery
    • Drug production
    • Gentic testing
    • Pharmacogenomics
    • Gene therapy
  • Product type

    • Gene recombinant drugs
    • Human vaccines
    • Blood products
    • Diagnostics reagents
    • Others

Currently, North America dominates the global red biotechnology market and is followed by Europe due to increased introduction of new products in the developed markets and number of patents and intellectual property rights granted in the biomedical sector. Emerging economies of Asia-Pacific, Latin America, Middle East and Africa are also expected to emerge as rapidly growing red biotechnology market in the near future due to increasing healthcare expenditure and technological advances.

Some of the major factors driving the global market for red biotechnology include breakthrough outcome of new medical therapies, increase in use of biocatalysis process in the synthesis and production of active pharmaceutical ingredients, advancements in biopharmaceuticals, increasing consumer awareness and government initiatives. However, high capital investment and technical limitations may pose a challenge to the growth of red biotechnology market.

Some of the market players in this industry include Amgen, Inc., Beijing Tiantan Biological Products Co., Ltd., Biogen Idec, Inc., Cephalon, Inc., Chiron Corporation, CSL Limited, Genentech, Inc., Genzyme Corporation, Gilead Sciences, Inc., MedImmune LLC, Serono SA and Shenyang Sunshine Pharmaceutical Co., Ltd.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments 


Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.


To receive discount, please click on the button below.

Please click on the button below to customize this report.

 
 
Back To Top